Jacobus Pharmaceutical Company Ruzurgi (amifampridine) Tablets 10 mg recall — FDA D-0008-2022
Microbial contamination of non-sterile products: Firm's testing found lots to exceed specification for aerobic bacteria, yeast, and mold counts.
Overview of recall records associated with Jacobus Pharmaceutical Company Inc., including dates, categories and classifications where available.
Classification mix: Class I: 1.
Microbial contamination of non-sterile products: Firm's testing found lots to exceed specification for aerobic bacteria, yeast, and mold counts.
This page summarizes recall records in which the official source identifies Jacobus Pharmaceutical Company Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.